Neil Shneider, MD
Enriched profileClaire Tow Professor of Motor Neuron Disorders; Director, Eleanor and Lou Gehrig ALS Center; Director, ALSA/ALS Clinic · Columbia University Irving Medical Center
Neil Shneider is Claire Tow Professor of Motor Neuron Disorders; Director, Eleanor and Lou Gehrig ALS Center; Director, ALSA/ALS Clinic at Columbia University Irving Medical Center. OpenAlex indexes 108 publications with 12,442 citations (h-index 40); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 1 Sept 2026
Neil A. Shneider, MD, PHD, is Claire Tow Professor of Motor Neuron Disorders at Columbia University Irving Medical Center, Department of Neurology (Vagelos College of Physicians and Surgeons). The public record shows 108 publications with 12,442 citations (h-index 40), centered on Amyotrophic Lateral Sclerosis Research, Neurogenetic and Muscular Disorders Research, RNA Research and Splicing. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 6 companies, 9 NIH-funded awards (1999–2026).
- Most recent indexed publication: 2026 · Nature immunology
- Top research focus: Amyotrophic Lateral Sclerosis Research
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 6 companies
Generated from the cited public record · current as of 1 Sept 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 12 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 60.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Co-chair
Translating Fundamental Research into Potential ALS Therapies Working Group, NIH/NINDS ALS Strategic Planning Workshop
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mr.research.columbia.edu ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 1 Sept 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- PREVENT ALL ALS Study
Sponsor: St. Joseph's Hospital and Medical Center, Phoenix
- ASSESS ALL ALS Study
Sponsor: St. Joseph's Hospital and Medical Center, Phoenix
- Regulatory T Cells for Amyotrophic Lateral Sclerosis
Sponsor: Cellenkos, Inc.
Industry payments
Updated 1 Sept 2026
6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Regeneron Pharmaceuticals, Inc.Program year20257 payments
- Ionis Pharmaceuticals, Inc.Program year20251 payment
- Merck Sharp & Dohme LLCProgram year20245 payments$10,735openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
66.7%Benzothiazole49.2%Riluzole100%Part D≥25 patientsSigma-1 Agonist17.5%Nuedexta100%Part D<11 patientsMusculoskeletal
23.7%gamma-Aminobutyric Acid-ergic Agonist23.7%Baclofen100%Part D<11 patientsRespiratory
9.6%Anticholinergic9.6%Glycopyrrolate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 1 Sept 2026
9 NIH research awards on record, funded 1999–2026 per NIH RePORTER. The latest:
- Silence ALS: A Platform for the Discovery and Development of Antisense Therapeutics for Patients with Ultra-Rare Forms of ALS
Columbia University Health Sciences
FY2026$5,151,818U01NS134684 - Access for All in ALS (ALL ALS) West Clinical Coordinating Center
St. Joseph'S Hospital and Medical Center
FY2025$20,235,572OT2NS136939 - Silence ALS: A Platform for the Discovery and Development of Antisense Therapeutics for Patients with Ultra-Rare Forms of ALS
Columbia University Health Sciences
FY2025$4,636,637U01NS134684
Publications
Updated 1 Sept 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Most-cited works
by citation count (OpenAlex)- 01Amyotrophic Lateral Sclerosis1,816 citations2001
- 02
- 03
- 04
- 05
Network
Updated 1 Sept 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 1 Sept 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/neil-shneider-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/neil-shneider-5252157a
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/in/neil-shneider-802013171
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature themWe list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 1 Sept 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- BA
Harvard College
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurology.columbia.edu ↗ - MD
Columbia University College of Physicians and Surgeons
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurology.columbia.edu ↗ - PhD
Columbia University (laboratory of Dr. Richard Axel)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurology.columbia.edu ↗ - Board Certified
Neurology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alscenter.cuimc.columbia.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nlorem.org ↗
- Director
Eleanor and Lou Gehrig ALS Center, Columbia University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alscenter.cuimc.columbia.edu ↗ - Director
ALSA/ALS Clinic, Columbia University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurology.columbia.edu ↗
Awards & honors
honors on the public record- 2025 Sheila Essey Award for ALS Research (American Academy of Neurology / The ALS Association)
$50,000 prize, presented at 2025 AAN Annual Meeting
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alsnetwork.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alscenter.cuimc.columbia.edu ↗
Secondary affiliations
appointments beyond the home institution- Member
Center for Motor Neuron Biology and Disease, Columbia University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alscenter.cuimc.columbia.edu ↗ - Member
H. Houston Merritt Clinical Research Center, Columbia University
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →neurology.columbia.edu ↗ - Attending Neurologist
NewYork-Presbyterian Hospital / Columbia University Irving Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurology.columbia.edu ↗
Media & interviews
press, podcasts and appearances- Guest
n-Lorem Foundation Patient Empowerment Program podcast, episode "Anna's Story of Hope and Help: FUS-ALS" (discussed Jacifusen/JaciFUSen ASO therapy with Stan Crooke and Sonja Kämpfer)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nlorem.org ↗ - Featured
"A Commitment to Conquering ALS," NewYork-Presbyterian Advances for Medical Professionals
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nyp.org ↗ - Featured
"Experimental Drug May Benefit Some Patients with Rare Form of ALS," Columbia University Irving Medical Center newsroom
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cuimc.columbia.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Stanley Fahn, MD
Columbia University Irving Medical Center
Rebecca Hahn, MD
Columbia University Irving Medical Center
Susheel Kodali, MD
Columbia University Irving Medical Center
Ronald Wapner, MD
Columbia University Irving Medical Center